Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Quality & Safety in Health Care|June 5, 2007
What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary careM L van Driel, S Coenen, K Dirven, et al.
Clinical Pharmacology and Therapeutics|February 28, 2013
When direct health-care professional communications have an impact on inappropriate and unsafe use of medicinesK C Reber, S Piening, J E Wieringa, et al.
Quality & Safety in Health Care|February 11, 2009
Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patientsJ E van Doormaal, P M L A van den Bemt, P G M Mol, et al.
International Journal of Medical Informatics|June 16, 2014
Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patientsK M Vermeulen, J E van Doormaal, R J Zaal, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2021
[Reducing the use of medication in the elderly; why or why not?]P Denig, M Edelman, K Taxis
Quality & Safety in Health Care|November 27, 2002
Scope and nature of prescribing decisions made by general practitionersP Denig, C L M Witteman, H W Schouten
International Journal of Clinical Practice|April 30, 2016
Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive studyF M de Vries, J Voorham, E Hak, et al.
Current Medical Research and Opinion|September 12, 2015
Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patientsF M de Vries, J Voorham, E Hak, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2020
Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping reviewM P Oktora, K P Kerr, E Hak, et al.
International Journal of Technology Assessment in Health Care|January 5, 2002
Assessment of new cardiovascular drugs. Relationships between considerations, professional characteristics, and prescribingN F Wieringa, P Denig, P A de Graeff, et al.
Pageof 7